Project cooperationUpdated on 13 August 2025

Looking for Clinical trial of early diagnosis of kidney damage in patients

Bülent BIDI

CEO at Argeron Medikal Araştırma Sanayi ve Ticaret A.Ş.

Antalya, Türkiye

About

How it Works?

The solution is used in conjunction with common urine glucose measurement kits to determine trehalase activity, a key marker of kidney function. By analyzing this specific enzyme, Nephrotest helps healthcare professionals identify potential acute kidney injury at an early stage. This is particularly useful for hospitalized and intensive care patients, where early detection can lead to timely intervention and improved outcomes.

Why is Argeron Nephrotest Important?

  • Early & Accurate Detection: Unlike some traditional tests, Nephrotest provides a rapid, widespread, and economical method for the early identification of kidney damage, even before symptoms become apparent.

  • Effective Monitoring: It allows for the regular monitoring of patients with risk factors, enabling more proactive and effective management of kidney health.

  • Patient Safety: By helping to detect adverse effects of medications or complications from other diseases, it plays a significant role in patient safety and reducing healthcare costs associated with advanced kidney failure.

Stage

  • Execution

Topic

  • Biotechnology

Type

  • Research

Similar opportunities